tiprankstipranks
Advertisement
Advertisement

RPRX Stock Latest News

Royalty Pharma Shareholders Back Board, Pay and Flexibility
Company AnnouncementsRoyalty Pharma Shareholders Back Board, Pay and Flexibility
8d ago
8K
RPRX
Royalty Pharma Secures New $1.8 Billion Credit Facility
PremiumCompany Announcements
Royalty Pharma Secures New $1.8 Billion Credit Facility
15d ago
8K
RPRX
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
1M ago
RPRX
Royalty Pharma price target raised to $58 from $50 at JPMorgan
PremiumThe Fly
Royalty Pharma price target raised to $58 from $50 at JPMorgan
1M ago
RPRX
Royalty Pharma price target raised to $66 from $50 at Citi
PremiumThe Fly
Royalty Pharma price target raised to $66 from $50 at Citi
1M ago
RPRX
Royalty Pharma’s Earnings Call Signals Confident Growth
PremiumCompany AnnouncementsRoyalty Pharma’s Earnings Call Signals Confident Growth
1M ago
RPRX
Royalty Pharma price target raised to $57 from $51 at UBS
Premium
The Fly
Royalty Pharma price target raised to $57 from $51 at UBS
2M ago
RPRX
Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
Premium
Ratings
Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
2M ago
RPRX
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
PremiumCompany Announcements
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
2M ago
8K
RPRX
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
2M ago
RPRX
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
PremiumThe Fly
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
2M ago
JNJ
RPRX
Zymeworks price target raised to $48 from $33 at Evercore ISI
PremiumThe Fly
Zymeworks price target raised to $48 from $33 at Evercore ISI
3M ago
RPRX
ZYME
Royalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
PremiumThe FlyRoyalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
3M ago
RPRX
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
Premium
The Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
3M ago
ONC
JAZZ
Royalty Pharma price target raised to $50 from $45 at TD Cowen
Premium
The Fly
Royalty Pharma price target raised to $50 from $45 at TD Cowen
3M ago
RPRX
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
4M ago
J
W
Royalty Pharma Earnings Call Balances Strength And Risk
PremiumCompany Announcements
Royalty Pharma Earnings Call Balances Strength And Risk
4M ago
RPRX
Royalty Pharma price target raised to $51 from $45 at Goldman Sachs
PremiumThe Fly
Royalty Pharma price target raised to $51 from $45 at Goldman Sachs
4M ago
RPRX
Royalty Pharma price target raised to $61 from $56 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $61 from $56 at Morgan Stanley
4M ago
RPRX
Royalty Pharma sees FY26 portfolio receipts $3.275B-3.425B
PremiumThe FlyRoyalty Pharma sees FY26 portfolio receipts $3.275B-3.425B
4M ago
RPRX
Royalty Pharma reports Q4 portfolio receipts of $874M
Premium
The Fly
Royalty Pharma reports Q4 portfolio receipts of $874M
4M ago
RPRX
Royalty Pharma PLC (RPRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Royalty Pharma PLC (RPRX) Q4 Earnings Cheat Sheet
4M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >